LISATA THERAPEUTICS, INC. Research And Development Expense

Quick Answer

LISATA THERAPEUTICS, INC. reported Research And Development Expense of $17.68 million for the year ending 2021.

  • LISATA THERAPEUTICS, INC. showed an increase of +91.1% in Research And Development Expense from 2020 to 2021.
  • This data is from LISATA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 22, 2022.
  • XBRL data for this metric is available from 2010 to 2021 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 12 years of available data (2010 to 2021), LISATA THERAPEUTICS, INC.'s Research And Development Expense has grown by 130.1%.
  • Historical annual values: Fiscal year 2021: $17.68 million | Fiscal year 2020: $9.25 million | Fiscal year 2019: $10.80 million | Fiscal year 2018: $7.59 million | Fiscal year 2017: $15.84 million | Fiscal year 2016: $16.70 million | Fiscal year 2015: $23.90 million | Fiscal year 2014: $29.19 million | Fiscal year 2013: $16.92 million | Fiscal year 2012: $10.45 million | Fiscal year 2011: $7.72 million | Fiscal year 2010: $7.68 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: